DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ki Su | ko |
dc.contributor.author | Hong, Sung Woo | ko |
dc.contributor.author | Kim, Hyemin | ko |
dc.contributor.author | Cho, Minsoo | ko |
dc.contributor.author | Kim, Seonghoon | ko |
dc.contributor.author | Hur, Wonhee | ko |
dc.contributor.author | Yun, Seok Hyun | ko |
dc.contributor.author | Yoon, Seung Kew | ko |
dc.contributor.author | Hahn, Sei Kwang | ko |
dc.date.accessioned | 2015-11-20T08:59:08Z | - |
dc.date.available | 2015-11-20T08:59:08Z | - |
dc.date.created | 2015-06-30 | - |
dc.date.created | 2015-06-30 | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | RSC ADVANCES, v.5, no.60, pp.48615 - 48618 | - |
dc.identifier.issn | 2046-2069 | - |
dc.identifier.uri | http://hdl.handle.net/10203/200935 | - |
dc.description.abstract | Cancer theranostic systems using polymeric micelles are emerging for simultaneous diagnosis and therapy. In this work, we have developed hyaluronate (HA)-Flt1 peptide conjugate micelles encapsulating epirubicin for theranostic treatment of hepatocellular carcinoma. Intravital bioimaging without labelling and in vivo anti-tumor therapeutic effect clearly confirmed the feasibility of HA-Flt1 peptide conjugate/epirubicin micelles for target-specific theranostic treatment of liver cancers. | - |
dc.language | English | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.subject | HYALURONIC-ACID DERIVATIVES | - |
dc.subject | DRUG-DELIVERY SYSTEMS | - |
dc.subject | POLYMERIC MICELLES | - |
dc.subject | ANTI-FLT1 PEPTIDE | - |
dc.subject | CONJUGATE | - |
dc.subject | DOXORUBICIN | - |
dc.subject | NEOVASCULARIZATION | - |
dc.subject | NANOPARTICLES | - |
dc.subject | EPIRUBICIN | - |
dc.subject | RECEPTOR | - |
dc.title | Hyaluronate-Flt1 peptide conjugate/epirubicin micelles for theranostic application to liver cancers | - |
dc.type | Article | - |
dc.identifier.wosid | 000355738300056 | - |
dc.identifier.scopusid | 2-s2.0-84930653450 | - |
dc.type.rims | ART | - |
dc.citation.volume | 5 | - |
dc.citation.issue | 60 | - |
dc.citation.beginningpage | 48615 | - |
dc.citation.endingpage | 48618 | - |
dc.citation.publicationname | RSC ADVANCES | - |
dc.identifier.doi | 10.1039/c5ra07464a | - |
dc.contributor.nonIdAuthor | Kim, Ki Su | - |
dc.contributor.nonIdAuthor | Hong, Sung Woo | - |
dc.contributor.nonIdAuthor | Kim, Hyemin | - |
dc.contributor.nonIdAuthor | Cho, Minsoo | - |
dc.contributor.nonIdAuthor | Hur, Wonhee | - |
dc.contributor.nonIdAuthor | Yun, Seok Hyun | - |
dc.contributor.nonIdAuthor | Yoon, Seung Kew | - |
dc.contributor.nonIdAuthor | Hahn, Sei Kwang | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordPlus | HYALURONIC-ACID DERIVATIVES | - |
dc.subject.keywordPlus | DRUG-DELIVERY SYSTEMS | - |
dc.subject.keywordPlus | POLYMERIC MICELLES | - |
dc.subject.keywordPlus | ANTI-FLT1 PEPTIDE | - |
dc.subject.keywordPlus | CONJUGATE | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | NEOVASCULARIZATION | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | EPIRUBICIN | - |
dc.subject.keywordPlus | RECEPTOR | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.